Buscar

Mostrando ítems 1-10 de 22

Forearm Bone Density In Users Of Depo-provera As A Contraceptive Method.

Bahamondes, L; Perrotti, M; Castro, S; Faúndes, D; Petta, C; Bedone, A (1999)

Bone Density Among Long-term Users Of Medroxyprogesterone Acetate As A Contraceptive.

Paiva, L C; Pinto-Neto, A M; Faundes, A (1998)

Without a plan' but 'keeping on track': Views on contraception, pregnancy and abortion in Mexico City

Autor desconocido (Taylor and Francis, 2011)

Despite increased use of modern contraception among Mexican women, there has been a significant increase in abortions. Little is known about the experiences behind these trends. This study examines decision-making around ...

Emerging Female Contraceptives.

Bahamondes, Luis; Bahamondes, Maria Valeria; Fernandes, Arlete Maria dos Santos; Monteiro, Ilza (2011)

Pros And Cons Of Vaginal Rings For Contraceptive Hormone Delivery

Faundes A.; Brache V.; Alvarez F. (, 2004)

Hormonal Changes Associated With Bleeding During Low Dose Progestogen Contraception Delivered By Norplant Subdermal Implants.

Faúndes, A; Alvarez-Sanchez, F; Brache, V; Jimenez, E; Tejada, A S (1991)

Evaluation Of Four Different Contraceptive Vaginal Rings: Steroid Serum Levels, Luteal Activity. Bleeding Control And Lipid Profiles

Alvarez-Sanchez F.; Brache V.; Jackanicz T.; Faundes A. (, 1992)

A Randomized Clinical Trial Of The Effect Of Intensive Versus Non-intensive Counselling On Discontinuation Rates Due To Bleeding Disturbances Of Three Long-acting Reversible Contraceptives

Modesto W.; Bahamondes M.V.; Bahamondes L. (Oxford University Press, 2014)

Planejamento reprodutivo no Brasil: contracepção e a saúde biopsicossocial da mulherReproductive planning in Brazil: contraception and women’s biopsychosocial healthPlanificación reproductiva em Brasil: anticoncepción y salud biopsicossocial de la mujer

Souza, Débora Cândido de (Universidade Federal da Grande DouradosBrasilFaculdade de Ciências da SaúdeUFGD, 2022)

Delayed First Injection Of The Once-a-month Injectable Contraceptive Containing 25 Mg Of Medroxyprogesterone Acetate And 5 Mg Of E2-cypionate: Effects On Ovarian Function

Petta C.A.; Hays M.; Brache V.; Massai R.; Hua Y.; Alvarez-Sanchez F.; Croxatto H.; D'Arcangues C.; Cook L.A.; Bahamondes L. (, 2001)